|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: A radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu LX, Gu XF, Zhu YC and Zhu YZ:
Protective effects of novel single compound, Hirsutine on hypoxic
neonatal rat cardiomyocytes. Eur J Pharmacol. 650:290–297. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Horie S, Yano S, Aimi N, Sakai S and
Watanabe K: Effects of hirsutine, an antihypertensive indole
alkaloid from Uncaria rhynchophylla, on intracellular calcium in
rat thoracic aorta. Life Sci. 50:491–498. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lou C, Takahashi K, Irimura T, Saiki I and
Hayakawa Y: Identification of Hirsutine as an anti-metastatic
phytochemical by targeting NF-κB activation. Int J Oncol.
45:2085–2091. 2014.PubMed/NCBI
|
|
7
|
Lou C, Yokoyama S, Saiki I and Hayakawa Y:
Selective anticancer activity of hirsutine against HER2-positive
breast cancer cells by inducing DNA damage. Oncol Rep.
33:2072–2076. 2015.PubMed/NCBI
|
|
8
|
Garraway LA, Widlund HR, Rubin MA, Getz G,
Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J,
et al: Integrative genomic analyses identify MITF as a lineage
survival oncogene amplified in malignant melanoma. Nature.
436:117–122. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Golding SE, Rosenberg E, Valerie N,
Hussaini I, Frigerio M, Cockcroft XF, Chong WY, Hummersone M,
Rigoreau L, Menear KA, et al: Improved ATM kinase inhibitor
KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and
ERK prosurvival signaling, and inhibits migration and invasion. Mol
Cancer Ther. 8:2894–2902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Golding SE, Rosenberg E, Adams BR,
Wignarajah S, Beckta JM, O'Connor MJ and Valerie K: Dynamic
inhibition of ATM kinase provides a strategy for glioblastoma
multiforme radiosensitization and growth control. Cell Cycle.
11:1167–1173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hickson I, Zhao Y, Richardson CJ, Green
SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ and Smith
GC: Identification and characterization of a novel and specific
inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer
Res. 64:9152–9159. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Norbury CJ and Zhivotovsky B: DNA
damage-induced apoptosis. Oncogene. 23:2797–2808. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nair RR, Bagheri M and Saini DK:
Temporally distinct roles of ATM and ROS in
genotoxic-stress-dependent induction and maintenance of cellular
senescence. J Cell Sci. 128:342–353. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu H, Huang M, Yang F, Chen Y, Miao ZH,
Qian XH, Xu YF, Qin YX, Luo HB, Shen X, et al: R16, a novel
amonafide analogue, induces apoptosis and G2-M arrest via poisoning
topoisomerase II. Mol Cancer Ther. 6:484–495. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cai Y, Lu J, Miao Z, Lin L and Ding J:
Reactive oxygen species contribute to cell killing and
P-glycoprotein downregulation by salvicine in multidrug resistant
K562/A02 cells. Cancer Biol Ther. 6:1794–1799. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai B, Lyu H, Huang J, Wang S, Lee CK, Gao
C and Liu B: Combination of bendamustine and entinostat
synergistically inhibits proliferation of multiple myeloma cells
via induction of apoptosis and DNA damage response. Cancer Lett.
335:343–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kudoh T, Kimura J, Lu ZG, Miki Y and
Yoshida K: D4S234E, a novel p53-responsive gene, induces apoptosis
in response to DNA damage. Exp Cell Res. 316:2849–2858. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rudolf E, Kralova V, Rudolf K and John S:
The role of p38 in irinotecan-induced DNA damage and apoptosis of
colon cancer cells. Mutat Res. 741–742:27–34. 2013. View Article : Google Scholar
|
|
19
|
Ljungman M: The DNA damage response-repair
or despair? Environ Mol Mutagen. 51:879–889. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roos WP and Kaina B: DNA damage-induced
cell death by apoptosis. Trends Mol Med. 12:440–450. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valerie K and Povirk LF: Regulation and
mechanisms of mammalian double-strand break repair. Oncogene.
22:5792–5812. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lavin MF: Ataxia-telangiectasia: From a
rare disorder to a paradigm for cell signalling and cancer. Nat Rev
Mol Cell Biol. 9:759–769. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ito K, Takubo K, Arai F, Satoh H, Matsuoka
S, Ohmura M, Naka K, Azuma M, Miyamoto K, Hosokawa K, et al:
Regulation of reactive oxygen species by Atm is essential for
proper response to DNA double-strand breaks in lymphocytes. J
Immunol. 178:103–110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sanchez-Prieto R, Rojas JM, Taya Y and
Gutkind JS: A role for the p38 mitogen-activated protein kinase
pathway in the transcriptional activation of p53 on genotoxic
stress by chemotherapeutic agents. Cancer Res. 60:2464–2472.
2000.PubMed/NCBI
|
|
25
|
Kim J and Wong PK: Loss of ATM impairs
proliferation of neural stem cells through oxidative
stress-mediated p38 MAPK signaling. Stem Cells. 27:1987–1998. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ito K, Hirao A, Arai F, Takubo K, Matsuoka
S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y and Suda T:
Reactive oxygen species act through p38 MAPK to limit the lifespan
of hematopoietic stem cells. Nat Med. 12:446–451. 2006. View Article : Google Scholar : PubMed/NCBI
|
